Release Date: 15/11/19 17:04 Summary: Breaker completes placement to US fund Price Sensitive: No Download Document 182.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%